Bohui Innovation(SZ:300318)2023-07-13 11:15Group 1: Company Overview - Beijing Bohui Innovation Biotechnology Group Co., Ltd. operates three blood product production enterprises located in Hebei and Guangdong [1] - The company has established a blood product processing plant in Qujing, Yunnan, with a processing capacity of 1,500 tons [1] - A new blood product production facility is being constructed in Hohhot, Inner Mongolia, to expand plasma resources and market reach [1] Group 2: Production and Capacity - The company currently operates 15 plasma collection stations, with 2 additional stations under construction in Inner Mongolia [2] - The plasma collection volume is expected to maintain a growth trend, supported by the increasing number of operational stations [2] - The company has a certain scale of inventory plasma to ensure supply for the second half of the year [2] Group 3: Financial Performance - The company’s blood product business gross margin has significant room for improvement compared to the industry average due to factors like low collection scale and high costs [3] - The first quarter's revenue growth was driven by strong market demand and improved operational efficiency in plasma stations and factories [3] Group 4: Future Plans and Challenges - The timeline for the completion of the Inner Mongolia factory is uncertain due to regulatory approvals required for production [2] - The company conducts annual impairment tests on goodwill as per accounting standards, which may lead to recognition of impairment losses if recoverable amounts are lower than book values [3]